Pyxis Oncology, Inc.
42 SEC EDGAR filings indexed (CIK 0001782223) across 12 form types.
Filing profile
Pyxis Oncology, Inc. (PYXS) has 42 SEC filings indexed on SecFilingDex, across 12 form types filed over roughly 2 years, from March 21, 2024 to August 20, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 24 of these filings were disclosed in the twelve months to August 20, 2026. 4 of the 42 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 8Form 4Insider transaction · within 2 business days of transaction
- 88-KMaterial event · event-driven
- 810-QQuarterly report · quarterly
- 4DEF 14AProxy statement · annual (pre-meeting)
- 3DEFA14ASEC filing
- 310-KAnnual report · annual
- 2Form 3Initial insider ownership · within 10 days of becoming an insider
- 2SC 13G/A5%+ passive stake · event-driven
- 18-K/AMaterial event · event-driven
- 1PRE 14ASEC filing
- 1424B2Shelf prospectus · event-driven
- 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
Profile derived from 42 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- Form 40001193125-26-359525
- Form 40001193125-26-352206
- 8-K0001193125-26-347911
- 10-Q0001193125-26-347913
- Form 30000919574-26-004386
- 8-K0001193125-26-294613
- Form 40001193125-26-294708
- 8-K0001193125-26-271137
- 8-K0001193125-26-222818
- 10-Q0001193125-26-222843
- 8-K/A0001193125-26-193940
- DEF 14A0001193125-26-194032
- DEFA14A0001193125-26-194051
- Form 40001193125-26-124333
- Form 40001193125-26-124342
- Form 40001193125-26-124348
- Form 40001193125-26-124380
- Form 40001193125-26-124388
- 8-K0001193125-26-118525
- 10-K0001193125-26-118532
- 8-K0001193125-26-041169
- 8-K0001193125-25-323704
- 8-K0001193125-25-261689
- 10-Q0001193125-25-261696
- 10-Q0000950170-25-108906
- 10-Q0000950170-25-071996
- DEF 14A0000950170-25-059573
- DEFA14A0000950170-25-059575
- 10-K0000950170-25-040771
- 10-Q0000950170-24-124602
- SC 13G/A0001085146-24-005529
- SC 13G/A0001104659-24-114823
- DEF 14A0000950170-24-109337
- PRE 14A0000950170-24-106381
- 10-Q0000950170-24-097073
- Form 30000950170-24-071435
- 10-Q0000950170-24-059099
- DEF 14A0000950170-24-049154
- DEFA14A0000950170-24-049161
- 424B20001437749-24-010967
- SC 13D/A0000950170-24-041264
- 10-K0000950170-24-034868
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.